SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from s pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Annual Report/ForecastSCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory 26.01.2024 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.SCHOTT Pharma delivers on 2023 targets and continues profitable.
Operator: Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the Stevanato Group Third Quarter 2023 Financial Results Conference Call.